Sumitomo Dainippon Pharma Co Ltd (4506)

2.1200 -0.0400 (-1.85%)
Closed EUR Disclaimer

4506 Financial Summary

Sumitomo Pharma Co., Ltd. reported earnings results for the half year ended September 30, 2023. For the half year, the company reported sales was JPY 152,642 million compared to JPY 319,289 million a year ago. Net loss was JPY 67,741 million compared to JPY 7,283 million a year ago. Basic loss per share from continuing operations was JPY 170.51 compared to JPY 18.33 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
4506
Gross margin TTM 59.93%
Operating margin TTM -68.52%
Net Profit margin TTM -52.59%
Return on Investment TTM -19.93%
Total Revenue
Net Income
Title
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Total Revenue 82,386 76,956 75,686 95,279
Gross Profit 49,519 47,063 45,256 56,126
Operating Income -31,247 -34,931 -51,567 -108,572
Net Income -49,967 -28,876 -38,865 -56,010
Clear All
0Selected
Please try another search
4506
Quick Ratio MRQ 0.33
Current Ratio MRQ 0.63
LT Debt to Equity MRQ 53.63%
Total Debt to Equity MRQ 119.88%
Total Assets
Total Liabilities
Title
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Total Assets 1,059,970 1,148,855 1,140,702 1,134,742
Total Liabilities 716,377 736,810 723,679 727,960
Total Equity 343,593 412,045 417,023 406,782
Clear All
0Selected
Please try another search
4506
Cash Flow/Share TTM -693.01
Revenue/Share TTM 831.4
Operating Cash Flow -13.35%
Cash
Net Change in Cash
Title
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Cash From Operating Activities -56,235 -44,336 -130,161 -44,594
Cash From Investing Activities 5,667 -5,783 38,458 30,732
Cash From Financing Activities 27,318 11,231 33,566 -113,800
Net Change in Cash -23,940 -34,078 -49,003 -122,295
Clear All
0Selected
Please try another search

* In Millions of JPY (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.